Disruptive innovation, creating new markets and displacing the old, is currently in the midst of a “big bang.” Technology is serving as the catalyst and helping to develop new breakthroughs, which in turn are spurring on further developments. Hardware, wearable gadgets, and new medical technologies are raising the level of innovation in health care product development. These rapid advances are creating opportunities to advance research and connect patients to their care.
As these discoveries have accelerated, they have outpaced regulatory science and the regulatory bodies that oversee them. The result is friction between existing organizations that have adapted more quickly and those that have followed lagging regulations. As competition increases to develop, own, and implement these technologies, the gap will widen until regulations, in need of review and constant update, can be accelerated to keep pace.
Discussing these challenges is a distinguished panel at the DIA 2015 51st Annual Meeting, “Disruptive Forces in Health Care Innovation: Where Are They Leading Us?” The panel is chaired by Jeffrey Kasher, PhD, President, Patients Can’t Wait, LLC. Joining Dr. Kasher to discuss the Innovator role is Jack Andraka, Inventor of Early Diagnostic Test for Pancreatic Cancer, Visionary Teenage Scientist. From the patients’ perspective is Patricia Furlong, BSN, Founding President and CEO, Parent Project Muscular Dystrophy. Speaking for wearables is Angela Dunn, Trends Analyst, healthiscool. Two other speakers providing the regulatory perspective have been invited from the FDA and United States House of Representatives.
Join these visionaries to hear their thoughts on the challenges that organizations, individuals and regulators are faced with involving disruptive technology. The panel, “Disruptive Forces in Health Care Innovation: Where Are They Leading Us?”, will take place June 16, 1:30 – 3:00 pm ET at the DIA 2015 51st Annual Meeting. If you have your own questions, submit them to this distinguished panel by emailing email@example.com.
The meeting brings together a global network of life sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies. This year’s event offers more than 245 educational offerings throughout 20 tracks, 450+ exhibiting companies, and more than 125 representatives from global regulatory agencies. The meeting provides participants with a valuable opportunity to network with professionals from around the world, share knowledge, and build new relationships.